Best treatment approaches for malignant spinal cord compression.
D017024:Chemotherapy, Adjuvant; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000627:therapeutic use; D006397:Hematinics / Q000627:therapeutic use; D006801:Humans; D008017:Life Expectancy; D018696:Neuroprotective Agents / Q000627:therapeutic use; D019637:Orthopedic Procedures; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins; D013117:Spinal Cord Compression / Q000209:etiology / Q000628:therapy*; D013125:Spinal Neoplasms / Q000150:complications* / Q000556:secondary / Q000628:therapy*
D006397:Hematinics; D018696:Neuroprotective Agents; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa